Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ckj/sft135 http://scihub22266oqcxt.onion/10.1093/ckj/sft135 C4389154!4389154!25859345     free     free     free       Clin+Kidney+J 2014 ; 7 (1): 11-22 Nephropedia Template TP {{tp|p=25859345|t=2014. Nephrotoxicity of recent anti-cancer agents |pdf=|usr=}}{{25859345}} gab.com Text Nephrotoxicity of recent anti-cancer agents JO: Clin Kidney J http://www.kidney.de/pget.php?&tw=1&pmid=25859345 #FOAvip Cancer patients may develop a variety of kidney lesions that impair not only their immediate survival but also limit the adequate treatment of the underlying malignant process. This review summarizes the nephrotoxic potential of some of the most recently developed anti-cancer drugs, focusing on those interfering with the vascular endothelial growth factor and epidermal growth factor receptor pathways and mammalian target of rapamycin inhibitors. Thrombotic microangiopathy (haemolytic-uraemic syndrome), proteinuria, hypertension and magnesium depletion are the most common side effects. Also the risk for developing acute kidney injury in patients with advanced prostate cancer undergoing androgen deprivation therapy is discussed. Twit Text FOAVip Nephrotoxicity of recent anti-cancer agents ????Clin Kidney J http://www.kidney.de/pget.php?&tw=1&pmid=25859345 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25859345 #FOAvip English Wikipedia <ref>{{Cite pmid|25859345}}</ref> Nephrotoxicity of recent anti-cancer agents #MMPMID25859345 Lameire N Clin Kidney J 2014[Feb]; 7 (1): 11-22 PMID25859345show ga Cancer patients may develop a variety of kidney lesions that impair not only their immediate survival but also limit the adequate treatment of the underlying malignant process. This review summarizes the nephrotoxic potential of some of the most recently developed anti-cancer drugs, focusing on those interfering with the vascular endothelial growth factor and epidermal growth factor receptor pathways and mammalian target of rapamycin inhibitors. Thrombotic microangiopathy (haemolytic-uraemic syndrome), proteinuria, hypertension and magnesium depletion are the most common side effects. Also the risk for developing acute kidney injury in patients with advanced prostate cancer undergoing androgen deprivation therapy is discussed. äNephrotoxicity of recent anti-cancer agents (epmc).pdf DeepDyve Pubget Overpricing